SNCA and Parkinson disease: MPTP administration to mice with a selective inactivation of alpha-synuclein in a few cases resulted in a dopamine deficiency and the manifestation of early clinical symptoms of a dopaminergic system dysfunction typical of the early stages of PD [7], which indirectly indicated the activation of the compensatory mechanisms of DA/MPP+ neurotransmission.